No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
FRANCE – Regeneron Pharmaceuticals Inc and its partner Sanofi voluntarily withdrew their application to the US Food and Drug Administration to expand the use of their anti-cancer drug Libtayo in…
Read More
UNITED KINGDOM – Merk & Co’s checkpoint inhibitor Keytruda, which has been available for three years through the Cancer Drugs Fund (CDF), has now been approved for routine NHS use…
Read More
USA – US Food and Drug Administration (USFDA) has approved Merck & Co.’s immunotherapy Keytruda for use in early kidney cancer, making it the first treatment of its kind available…
Read More
USA- Gilead Sciences has tagged Merck in a study where Trodelvy (sacituzumab govitecan), a Trop-2 targeting antibody-drug conjugate will be paired with Merck’s Keytruda (pembrolizumab) in a new phase 3…
Read More
SWITZERLAND – Novartis has announced that the primary endpoints of a Phase 3 trial evaluating canakinumab drug failed in its second attempt, missing targets to improve overall survival rates for…
Read More
USA – The Food and Drug Administration (FDA) has given a positive nod to abemaciclib (Verzenio) in combination with endocrine therapy for adjuvant treatment of certain patients with early breast…
Read More